Sign up to save your podcasts
Or
Share From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care
The pace of change in cardiometabolic medicine is accelerating. Ian Neeland, MD, breaks down the latest innovations in incretin therapies, from oral medications to cutting-edge combinations, and what they mean for weight loss, heart health, and long-term patient care.
- Learn more about Daniel Simon, MD
- Learn more about Ian Neeland, MD
- View our Science@UH video podcast on YouTube
- Learn more about the University Hospitals Research & Education Institute
View all episodes
By University Hospitals Research and Education Institute
5
22 ratings
The pace of change in cardiometabolic medicine is accelerating. Ian Neeland, MD, breaks down the latest innovations in incretin therapies, from oral medications to cutting-edge combinations, and what they mean for weight loss, heart health, and long-term patient care.
- Learn more about Daniel Simon, MD
- Learn more about Ian Neeland, MD
- View our Science@UH video podcast on YouTube
- Learn more about the University Hospitals Research & Education Institute